• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM S.R.L. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM S.R.L. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-S
Device Problem Perivalvular Leak (1457)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 11/06/2023
Event Type  Injury  
Manufacturer Narrative
H3 other text : still implanted (under monitoring).
 
Event Description
On (b)(6) 2023, a perceval valve size s was implanted in a patient through full sternotomy.This was a redo avr to replace the degenerated 19mm trifecta valve which was implanted in 2017.Post implantation echo showed no pvl.Procedure was completed, patient was sent to icu and was discharged later on.As reported, patient was presented again after 20 days (b)(6) with chest pain and unable to do any physical activities.The new echo revealed moderate pvl.After discussion, it was decided that the repositioning of the valve is not a feasible option as the patient is very frail and will not be able to take stress from cpb.Based on the further information received, this was an isolated procedure, and the valve was positioned supra-annular.Echo shows good functionality of the valve.No positioning difficulty were noted.Reportedly, a small tear noticed after explanting the degenerated trifecta valve which was repaired before implanting the perceval valve.The patient has been closely monitored and has been advised for amplatzer plug to be implanted in january for pvl management.
 
Event Description
On (b)(6) 2023, a perceval plus valve size s was implanted in a patient through full sternotomy.This was a redo avr to replace the degenerated 19mm trifecta valve which was implanted in 2017.Post implantation echo showed no pvl.Procedure was completed, patient was sent to icu and was discharged later on.As reported, patient was presented again after 20 days (~ (b)(6)) with chest pain and unable to do any physical activities.The new echo revealed moderate pvl with good valve functionality.After discussion, it was decided that the repositioning of the valve was not a feasible option as the patient is very frail and would not be able to take stress from cpb.Based on the further information received, no concomitant procedures were performed at the time of perceval valve implant and the valve was positioned supra-annular.No positioning difficulties were noted.Reportedly, a small tear was noticed after explanting the degenerated trifecta valve which was repaired before implanting the perceval prosthesis.The patient has been closely monitored and has been treated with an amplatzer plug implant in (b)(6) 2024 to correct the pvl.Reportedly, the procedure has been completed with good results and the patient is doing fine with trivial leak and good hemodynamics.
 
Manufacturer Narrative
The manufacturer is further investigating to assess the possible root cause of the reported event.A follow up report will be submitted at the completion of the investigation or upon receipt of any additional information.
 
Manufacturer Narrative
A complete manufacturing and material records review for the sutureless valve pvf-s sn: (b)(6) involved in the reported event has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.The manufacturer is following up with the site to retrieve additional information on the event and the device involved.A follow up report will be provided upon receipt of further information.H3 other text: still implanted (under monitoring).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM S.R.L.
strada crescentino
saluggia, vc
Manufacturer (Section G)
CORCYM S.R.L.
strada crescentino
saluggia, vc 13040
IT   13040
Manufacturer Contact
laura mannino
5005 north fraser way
burnaby, bc V5J 5-M1
CA   V5J 5M1
MDR Report Key18403078
MDR Text Key331482665
Report Number3005687633-2023-00131
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011/S013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVF-S
Device Catalogue NumberPVF-S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/28/2023
Initial Date FDA Received12/27/2023
Supplement Dates Manufacturer Received01/19/2024
03/04/2024
Supplement Dates FDA Received02/16/2024
04/03/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/16/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age78 YR
Patient SexFemale
-
-